Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 142,182
  • Shares Outstanding, K 161,809
  • Annual Sales, $ 351,410 K
  • Annual Income, $ 880 K
  • EBIT $ 93 M
  • EBITDA $ 95 M
  • 60-Month Beta 0.30
  • Price/Sales 0.36
  • Price/Cash Flow 15.66
  • Price/Book N/A
  • Price/Earnings ttm 38.72
  • Earnings Per Share ttm 0.02
  • Most Recent Earnings $0.02 on 02/27/25
  • Next Earnings Date 05/08/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 453.15% ( +141.93%)
  • Historical Volatility 137.99%
  • IV Percentile 94%
  • IV Rank 56.24%
  • IV High 784.43% on 03/14/25
  • IV Low 27.36% on 06/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 212
  • Volume Avg (30-Day) 106
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 3,357
  • Open Int (30-Day) 2,435

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 4
  • High Estimate 0.05
  • Low Estimate -0.04
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5910 +50.34%
on 04/14/25
1.5200 -41.55%
on 03/26/25
-0.6115 (-40.77%)
since 03/25/25
3-Month
0.5910 +50.34%
on 04/14/25
4.0300 -77.95%
on 01/28/25
-2.8215 (-76.05%)
since 01/24/25
52-Week
0.5910 +50.34%
on 04/14/25
8.4500 -89.49%
on 05/03/24
-7.1915 (-89.00%)
since 04/25/24

Most Recent Stories

More News
Ironwood Shares Tank on Regulatory Update for Apraglutide

Shares of Ironwood Pharmaceuticals IRWD plunged 31.5% yesterday after it announced regulatory updates on the next-generation GLP-2 analog, apraglutide, which is being developed for treating short bowel...

KRYS : 168.06 (-0.63%)
IRWD : 0.8885 (+1.12%)
JAZZ : 110.80 (+1.67%)
ADMA : 21.86 (-2.10%)
Ironwood: Q4 Earnings Snapshot

Ironwood: Q4 Earnings Snapshot

IRWD : 0.8885 (+1.12%)
Ironwood: Q3 Earnings Snapshot

Ironwood: Q3 Earnings Snapshot

IRWD : 0.8885 (+1.12%)
Implied Volatility Surging for Ironwood (IRWD) Stock Options

Investors in Ironwood Pharmaceuticals, Inc. IRWD need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $2.50 Put had some of the highest...

IRWD : 0.8885 (+1.12%)
Ironwood: Q2 Earnings Snapshot

Ironwood: Q2 Earnings Snapshot

IRWD : 0.8885 (+1.12%)
Ironwood: Q1 Earnings Snapshot

Ironwood: Q1 Earnings Snapshot

IRWD : 0.8885 (+1.12%)
Ironwood: Q4 Earnings Snapshot

Ironwood: Q4 Earnings Snapshot

IRWD : 0.8885 (+1.12%)
Chart of the Day: Ironwood Pharma - Gastrointestinal Products

The Chart of the Day belongs to the gastrointestinal pharmaceutical products company Ironwood Pharmaceutical (IRWD) I found the stock by using Barchart's powerful screening functions to find stocks...

IRWD : 0.8885 (+1.12%)
Ironwood: Q3 Earnings Snapshot

Ironwood: Q3 Earnings Snapshot

IRWD : 0.8885 (+1.12%)

Business Summary

Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic...

See More

Key Turning Points

3rd Resistance Point 1.0552
2nd Resistance Point 0.9944
1st Resistance Point 0.9415
Last Price 0.8885
1st Support Level 0.8278
2nd Support Level 0.7670
3rd Support Level 0.7141

See More

52-Week High 8.4500
Fibonacci 61.8% 5.4479
Fibonacci 50% 4.5205
Fibonacci 38.2% 3.5931
Last Price 0.8885
52-Week Low 0.5910

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar